Response to correspondence concerning: "Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients"
Int J Infect Dis
.
2021 Feb:103:478-479.
doi: 10.1016/j.ijid.2020.12.008.
Epub 2020 Dec 9.
Authors
A J J Lammers
1
,
R M Brohet
2
,
R E P Theunissen
3
,
C Koster
3
,
R Rood
4
,
D W M Verhagen
5
,
K Brinkman
6
,
R J Hassing
7
,
A Dofferhoff
8
,
R El Moussaoui
9
,
G Hermanides
10
,
J Ellerbroek
11
,
N Bokhizzou
12
,
H Visser
13
,
M van den Berge
14
,
H Bax
15
,
D F Postma
16
,
P H P Groeneveld
3
Affiliations
1
Isala, Zwolle, The Netherlands. Electronic address: a.j.j.lammers@isala.nl.
2
Department of Epidemiology and Statistics, Isala Academy, Zwolle, The Netherlands.
3
Isala, Zwolle, The Netherlands.
4
Diakonessen Hospital, Utrecht, The Netherlands.
5
Medisch Centrum Jan van Goyen, Amsterdam, The Netherlands.
6
OLVG, Amsterdam, The Netherlands.
7
Rijnstate, Arnhem, The Netherlands.
8
Canisius Wilhelmina Hospital, Nijmegen, The Netherlands.
9
Maasstad Hospital Rotterdam, The Netherlands.
10
Rode Kruis Hospital, Beverwijk, The Netherlands.
11
Reinier de Graaf Gasthuis, Delft, The Netherlands.
12
BovenIJ Hospital, Amsterdam, The Netherlands.
13
Beatrix Hospital Gorinchem, The Netherlands.
14
Admiraal de Ruiter Hospital, Goes, The Netherlands.
15
Erasmus MC Rotterdam, The Netherlands.
16
University Medical Center Groningen, Groningen, The Netherlands.
PMID:
33310107
PMCID:
PMC7836922
DOI:
10.1016/j.ijid.2020.12.008
No abstract available
Publication types
Letter
Comment
MeSH terms
COVID-19 Drug Treatment*
Chloroquine / therapeutic use
Humans
Hydroxychloroquine* / therapeutic use
Intensive Care Units
SARS-CoV-2
Substances
Hydroxychloroquine
Chloroquine